Biotech buys get pharma M&A off to flying start in 2015
March 05, 2015 at 08:25 AM EST
LONDON, March 5 (Reuters) - AbbVie's $21 billion deal to buy Pharmacyclics shows big pharma's hunger for new drugs at a time when research at smaller biotechnology companies is driving some of the most promising advances in medicine.
